Jump to content

Karnofsky Performance Status Scale

Original Editor - User Name

Top Contributors - Joey Pease and Vidya Acharya  

Objective

The Karnofsky Performance Scale (KPS) is a standardised tool used to assess a patient's functional status, particularly in those with chronic or terminal illnesses. [1] Introduced by Dr. David A. Karnofsky and colleagues in 1949 as part of a study on nitrogen mustards for carcinoma treatment, the scale has evolved to remain a cornerstone in evaluating a patient's ability to perform daily activities, determining prognosis, guiding treatment decisions, and monitoring patient status. [2] [1]

Intended Population

The KPS is primarily intended for patients with serious illnesses, especially cancer, where disease progression significantly impacts physical functioning. It is widely utilised in oncology, palliative care, and hospice settings to monitor patient status and guide care planning.

Method of Use

The KPS describes a patient’s functional status as a comprehensive 11-point scale correlating to percentage values ranging from 100% (no evidence of disease, no symptoms) to 0% (death). Each percentage reflects the patient’s ability to perform daily activities and their level of independence or care needs. For instance, 100% indicates full independence, while 10% describes a moribund state with rapid disease progression.

100% The patient has no complaints and is without evidence of disease
90 The patient has minor signs/symptoms, but is able to carry out his or her normal activities
80 The patient demonstrates some signs/symptoms and requires some effort to carry out normal activities
70 The patient is able to care for self, but is unable to do his or her normal activities or active work
60 The patient is able to care for self, but requires occasional assistance
50 The patient requires medical care and much assistance with self care
40 The patient is disabled and requires special care and assistance
30 The patient is severely disabled and hospitalisation is indicated; Death is not imminent
20 The patient is very ill with hospitalisation and active life‑support treatment necessary
10 The patient is moribund with fatal process proceeding rapidly
0 Dead

[2][3]

Evidence

Reliability

Research has demonstrated high inter-rater reliability for the KPS, especially when clinicians are appropriately trained. The KPS scores are consistent across different healthcare professionals, particularly in controlled clinical settings, enhancing its applicability for longitudinal studies and patient monitoring.

A study by Mor et al. (1984) [4] reported an inter-rater reliability coefficient of 0.97 among 47 interviewers, indicating excellent reliability.

Validity

The KPS is widely validated as an indicator of functional status in oncology. Studies correlate KPS scores with survival rates and quality of life outcomes. It is considered a valid measure when used to predict treatment tolerance and survival in patients with advanced illness, making it a valuable tool for clinicians.

Schag et al. (1984) demonstrated the KPS's construct validity by showing significant correlations with physical and psychosocial difficulties in cancer patients.[5]

The scale’s high inter-rater reliability and validated correlation with survival outcomes make it a dependable tool for clinicians when evaluating treatment plans or tracking disease progression.

Limitations

The original Karnofsky Performance Status scale had several limitations that made it less suited for contemporary care. It was initially designed with a focus on hospital-based care, which restricts its applicability to community or home-based settings, now common in modern palliative care. The scale primarily emphasised physical function, overlooking important psychosocial, emotional, and cognitive aspects of a patient’s well-being that are essential for holistic care. Its rigid categorisations and prescriptive language could limit flexibility, particularly for patients with complex conditions or those in diverse care settings. Furthermore, the KPS was tied to assumptions about available resources and clinical treatments, which may not align with today’s patient-centred and resource-diverse care models. The language and phrasing also reflect healthcare practices of the 1940s, making it less practical for modern multidisciplinary teams. These limitations led to the development of modified versions, such as the Thorne-modified Karnofsky Performance Status (TKPS) scale and the Australian-modified Karnofsky Performance Status (AKPS) scale to adapt the scale for contemporary use and better address the needs of patients in varied care settings. [6]

Modifications

Thorne-modified Karnofsky Performance Status (TKPS)

In the late 1990s, Thorne introduced a modified version of the KPS, developed to prioritise community-based care, enhancing its relevance to palliative settings. The TKPS revised the lower categories of the original scale to reflect professional care needs and activity levels, removing mention of care location.[6] In 2000, Nikoletti and colleagues validated the TKPS in a sample of 78 Australian home-hospice patients, suggesting it offers a more objective and sensitive measure of functional performance in this setting. [7]

Australia-modified Karnofsky performance status (AKPS)

The Australia-modified KPS (AKPS) integrates elements of both the KPS and TKPS, making it adaptable to any care setting.[6]The categories in the AKPS are less prescriptive about the expected care location, but much of the original KPS and TKPS wording has been preserved to minimise confusion and avoid extensive retraining for clinicians familiar with the earlier versions. For example, 30% in the original KPS is described as severely disabled, hospitalisation necessary whereas the modifications describe 30% as almost completely bedfast which takes into account different care locations and this person could be receiving care in the community rather than hospitalisation being a necessity. [6]

Comparison of the original Karnofsky Performance Status Scale (KPS), Thorne-modified Karnofsky Performance Status Scale (TKPS), and the Australia-modified Karnofsky Performance Status Scale (AKPS). Italicised areas reflect the original KPS instrument. [6]
Comparison of the original Karnofsky Performance Status Scale (KPS), Thorne-modified Karnofsky Performance Status Scale (TKPS), and the Australia-modified Karnofsky Performance Status Scale (AKPS). Italicised areas reflect the original KPS instrument. [6]


The Karnofsky Performance Scale remains an essential tool in assessing functional status and guiding care for patients with serious illnesses. Modifications such as the TKPS and AKPS have ensured its continued applicability in diverse care environments, highlighting its adaptability and value in contemporary healthcare.




References

  1. ↑ 1.0 1.1 Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma: with particular reference to bronchogenic carcinoma. Cancer. 1948 Nov 15.
  2. ↑ 2.0 2.1 Gaillard F, Glick Y, Karnofsky performance status. Reference article, Radiopaedia.org (Accessed on 11 Nov 2024) https://doi.org/10.53347/rID-98727
  3. ↑ National Institute for Health and Care Excellence. Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer) Appendix D Karnofsky performance score: NICE; 2001 [updated 2016 March]. (Technology appraisal guidance). Available from: https://www.nice.org.uk/guidance/ta23/chapter/appendix-d-karnofsky-performance-score
  4. ↑ Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky performance status scale: an examination of its reliability and validity in a research setting. Cancer. 1984 May 1;53(9):2002-7.
  5. ↑ Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. Journal of Clinical Oncology. 1984 Mar;2(3):187-93.
  6. ↑ 6.0 6.1 6.2 6.3 6.4 Abernethy AP, Shelby-James T, Fazekas BS, Woods D, Currow DC. The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]. BMC palliative care. 2005 Dec;4:1-2.
  7. ↑ Nikoletti S, Porock D, Kristjanson LJ, Medigovich K, Pedler P, Smith M. Performance status assessment in home hospice patients using a modified form of the Karnofsky Performance Status Scale. Journal of palliative medicine. 2000 Sep 1;3(3):301-11.